
Q-Zac 50 SR Tablet
Marketer
Dorris Pharmaceutical Pvt Ltd
Salt Composition
Quetiapine (50mg)
Overview Q-Zac 50 SR Tablet
Zacquinavir 50mg extended-release tablets treat schizophrenia (a condition causing hallucinations, delusions, and impaired thinking/behavior) and manic episodes. They're also used for bipolar disorder management. This medication can be taken with or without food, but consistent daily timing ensures stable blood levels. Follow your doctor's prescribed dosage and duration. If you miss a dose, take it immediately upon remembering. Sudden discontinuation is dangerous and may exacerbate symptoms; consult your doctor before stopping. Immediately cease use if Neuroleptic malignant syndrome (NMS) develops (fever, muscle stiffness, altered mental state, or seizures). Common side effects include low hemoglobin, elevated triglycerides, reduced cholesterol, headache, extrapyramidal symptoms, dry mouth, and withdrawal symptoms. Postural hypotension (sudden blood pressure drops upon standing) may occur initially; rise slowly. Dizziness and drowsiness are possible; avoid driving or tasks requiring alertness until effects are known. Weight gain is a potential side effect, mitigated by diet and exercise. Increased diabetes risk necessitates regular glucose monitoring. Report any unusual mood shifts, new or worsening depression, or suicidal ideation to your physician.
Uses of Q-Zac 50 SR Tablet
Managing Manic Episodes | Treating Schizophrenia
Major Benefits of Q-Zac 50 SR Tablet:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Q-Zac 50 SR Tablets can be consumed with or without food, though consistent timing is recommended.
Common Side effects of Q-Zac 50 SR Tablet:
- Weight gain
- Constipation
- Dizziness
- Dryness in mouth
- Fatigue
- High blood pressure
- Orthostatic hypotension (sudden lowering of blood pressure on standing)
- Sleepiness
- Dyslipidemia
- Increased appetite
How to use Q-Zac 50 SR Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Q-Zac 50 SR Tablet whole; do not chew, crush, or divide it. This medication can be administered with or without food, though consistent timing is recommended.
How Q-Zac 50 SR Tablet works:
ZacQuell 50mg extended-release tablets are an atypical antipsychotic medication. Their mechanism of action involves regulating neurotransmitters in the brain, thereby influencing cognitive processes.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol use with Q-Zac 50 SR Tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Extended-release Q-Zac 50mg tablets may pose pregnancy risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible hazards prior to prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Q-Zac 50 SR Tablet while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Driving may be impaired by Q-Zac 50 SR Tablet, which can cause drowsiness, dizziness, and blurred vision. Avoid operating a vehicle if experiencing these side effects.
KidneySAFE IF PRESCRIBED
The use of Q-Zac 50 SR Tablet in patients with kidney disease appears to pose minimal risk. Existing evidence indicates dose modification may be unnecessary, however, physician consultation is recommended.
LiverCAUTION
Patients with liver impairment should use Q-Zac 50 SR Tablets cautiously, potentially requiring dosage modification. Physician consultation is advised.
What if you forget to take Q-Zac 50 SR Tablet :
Should you forget to take a Q-Zac 50 SR Tablet, administer it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Q-Zac 50 SR Tablet
| Label | Value |
|---|---|
| Chemical Type | Dibenzothiazepine Compounds |
| Developing Habits | No. |
| Treatment Category | Neuroscience, Central Nervous System |
